Micro Therapeutics' Thrombolytic Brush:
This article was originally published in Clinica
Executive Summary
US company Micro Therapeutics has received approval to market its over-the-wire Thrombolytic Brush for cleaning haemodialysis access grafts which regularly gets clogged with blood. The device contains a removable 0.035 inch guidewire system that allows the clinician to maintain continual access for the duration of the procedure. It is designed for rapid interventional clot disruption and dissolution by mixing urokinase, a thrombolytic drug, with the blood clot.